Effectiveness of a Self-applied Multi-component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: A Randomized Clinical Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Grief
- Sponsor
- Universidad Internacional de Valencia
- Enrollment
- 43
- Locations
- 1
- Primary Endpoint
- Decrease in the scores of the Center for Epidemiologic Studies Depression (CES-D) scale
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This study evaluates the effectiveness of an online Multi-component psychological intervention, that is focused on providing self-support to the Mexican population for the prevention of complicated grief disorder, by reducing grief and strengthening the capacities of the person to handle losses derived from COVID-19 as well as reducing the symptoms of anxiety, depression, hopelessness, and post-traumatic stress, and increasing the quality of sleep and perception of the quality of life.
Detailed Description
The loss of a loved one is perhaps one of the most shocking events in the life of a person. Grief is an emotional experience universal human, unique and painful, that can be delimited in time, which allows the person to adapt to loss and the new reality. In situations, prior to COVID-19, there was a risk of suffering prolonged grief when going through the death of a family member hospitalized and unable to say goodbye. The global COVID-19 pandemic is expected to have a major impact related to the experience of death, dying, and grief, which will make the grieving process difficult. The confusion, anger, and post-traumatic stress are some of the negative effects related to quarantine. It is not only difficult to deal with the loss of the person but at the same time with the interruption of rituals and practices associated with a death such as funerals and burials, which are postponed and performed without the presence of family. Given such data, it is necessary to intervene with proposals that help improve mental health and the management of grief. To provide treatment in such conditions where face-to-face sessions are not possible, and the number of patients surpasses the number of available therapists it will be implemented an online intervention based on Cognitive Behavioral Therapy, Mindfulness, Behavioral Activation Therapy, and Positive Psychology. The Online Intervention system "Grief COVID" will be delivered in 12 modules interconnected. The objective of this study is to assess the efficacy and moderators of change of this intervention for the reduction of symptoms of anxiety, depression, hopelessness, and post-traumatic stress, and the increase of the quality of sleep and perception of the quality of life. The contents of this intervention will be implemented through a responsive web application. In order to create the most fitted intervention for the real needs of the participants will be created following the principles of User Experience (UX), with this ensuring that the design characteristics of the tool will meet the desired requirements to be perceived as easy to use, attractive and useful. The UX approach refers to the experience that a user has with a product, with special emphasis on human-product interaction. This study will have an experimental and control group. The experimental group will receive the intervention to prevent complicated grief, and the control group will be on the waiting list. Participants will be randomly assigned to one of the two groups. Participants in the control group once their data have been collected and the time elapsed after receiving the intervention in the participants in the experimental group will receive access to the intervention and will also be evaluated in order to increase the sample level and to be able to have more results about the effectiveness of the intervention. In both conditions, the participants will be measured at pre and post moments. The subjective measures will include the following Psychometrics: 1. Depression scale of the Center for Epidemiological Studies. 2. The abbreviated depression, anxiety, and stress scale (DASS-21). 3. Plutchik Suicide Risk Scale. 4. Pittsburgh Sleep Quality Index. 5. Post-traumatic diagnostic scale. 6. Satisfaction with Life Scale. 7. Beck's Hopelessness Scale. 8. Generalized Anxiety Scale (GAD-7). 9. Opinion on the treatment. 10. System usability scale.
Investigators
Eligibility Criteria
Inclusion Criteria
- •To have access to a communication device with access to the internet (computer, tablet, and mobile).
- •To have a valid email address.
- •To have basic digital skills in the use of an operational system and internet browsing.
- •To understand Spanish since all the contents are in this language.
- •Having suffered the loss of a loved one in a period of no less than 3 months and no longer than 6 months.
- •Symptoms of General Anxiety Disorder and/or Depression and/or, grief symptoms.
Exclusion Criteria
- •To have a diagnosis of psychotic disorder
- •To be receiving psychological and/or pharmacological treatment during the study
- •Moderate to high score on the suicide scale
- •Recent attempt of suicide (3 months)
- •Symptoms of posttraumatic Stress Disorder
Outcomes
Primary Outcomes
Decrease in the scores of the Center for Epidemiologic Studies Depression (CES-D) scale
Time Frame: 1.5 to 2 months, depending on the development of the patient and the completion of the 12 modules
Center for Epidemiologic Studies Depression (CES-D) is a structured self-report scale for evaluation depression symptoms. This scale assesses the number of depression symptoms within 2 weeks. The scale consists 20 items and contains 4-point score responses (0 to 3) as the following; rarely or none of the time (less than 1 day); some of a little of the time (1-2 days); occasionally or moderate amount of time (3-4 days) and most or all of the time (5-7 days). The total possible range of scores is from 0 to 60 where \^16 is the cut-off point for this scale, and higher scores indicate more symptoms of depression. It is expected a statistically significant decrease (P \< 0.05) in depression symptoms.
Change in the score of Anxiety Symptoms in the Depression Anxiety Stress Scale (DASS-21)
Time Frame: 1.5 to 2 months, depending on the development of the patient and the completion of the 12 modules
The Depression Anxiety Stress Scale-21 is a structured self-report scale that assesses the subscales of anxiety, depression, and stress symptoms over the past last week. Each subscale contains seven items with responses rated on a 4-point scale (0-3) as follows; 0 Did not apply at me at all; 1 Applied to me to a considerable degree or some of the time; 2 Applied to me to a considerable degree or a good part of the time; 3 Applied to me very much or most of the time. Each subscale has a cut-off point for depression (6), anxiety (5), and stress (6). It is expected a statistically significant decrease (P \< 0.05) in depression and anxiety symptoms.
Decrease in the score of The Pittsburgh Sleep Quality Index.
Time Frame: 1.5 to 2 months, depending on the development of the patient and the completion of the 12 modules
This instrument assesses the quality patterns of sleep. It differentiates the "poor" and "good" sleep by measuring seven areas, where the range score of answers are from 0 to 3, the global sum of this scale can be a value between 0 to 60, and the cutoff point is "5" that indicates a "poor" sleep quality. It is expected a statistically significant increase (P \< 0.05) in the Sleep Quality measure.
Decrease in the scores of the Post-Traumatic Stress Disorder Symptom Scale
Time Frame: 1.5 to 2 months, depending on the development of the patient and the completion of the 12 modules
The Post-Traumatic Stress Disorder Symptom Scale is a 17-item structured interview. The severity over the last 2 weeks of each item on the PSS is rated by the interviewer using a 4-point scale: 0 = not at all, 1 = a little bit, 2 = somewhat, and 3 = very much. The maximum possible score is 51 (severely affected) and the minimum possible score is 0 (total absence of the symptoms). The total severity score is calculated as the sum of the severity ratings for the 17 items. The diagnosis of the Post-Traumatic Stress Disorder Symptom Scale is made when at least 1 re-experiencing, 3 avoidance, and 2 arousal symptoms are endorsed on the scale by individuals who were traumatized at least one month prior to the assessment. It is expected a statistically significant decrease (P \< 0.05) in the symptoms of Post-Traumatic Stress Disorder in the patients suffering from this disorder.
Increase in Satisfaction with Life Scale
Time Frame: 1.5 to 2 months, depending on the development of the patient and the completion of the 12 modules
This instrument is composed of 5 items in which the participants must indicate how much they agree with each question, with an answer option in Likert format from 1 (totally disagree) to 7 (totally agree), the scores range from a minimum from 5 to a maximum of 35, where the highest scores indicate greater satisfaction with life. This scale has been validated in the Mexican population, obtaining good results of internal consistency (α = 0.74).
Decrease in the symptoms of General Anxiety Disorder
Time Frame: 1.5 to 2 months, depending on the development of the patient and the completion of the 12 modules
On the Generalized Anxiety Disorder 7-item (GAD-7) scale subjects are asked how often, during the last 2 weeks, they have been bothered by each of the 7 core symptoms of generalized anxiety disorder. Response options are "not at all," "several days," "more than half the days," and "nearly every day," scored as 0, 1, 2, and 3, respectively. Therefore, GAD-7 scores range from 0 to 21, with scores of ≥5, ≥10, and ≥15 represent mild, moderate, and severe anxiety symptom levels, respectively. Is expected a statistically significant decrease (P \< 0.05) in the General Anxiety symptoms.
Secondary Outcomes
- Decrease in the Plutchik Suicide Risk Scale(1.5 to 2 months, depending on the development of the patient and the completion of the 12 modules)
- Decrease in Grief symptoms(1.5 to 2 months, depending on the development of the patient and the completion of the 12 modules)